Saturday, March 15, 2025
HomeIndustriesHealthcare

Healthcare

Innovent Biologics and AnHeart Therapeutics Receive NMPA Breakthrough Designation for Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major...

Patent Issued for Multiomic Approach to Autism Spectrum Disorder Diagnosis

Quadrant Biosciences Inc. announced that the United States Patent and Trademark Office (USPTO) has issued the company and its partners, the SUNY Research Foundation...

Caring Cross Presents Research Involving Anti-HIV DuoCAR-T Cell Therapy at the Conference on Retroviruses and Opportunistic Infections (CROI) 2022

Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to cures for all patients, everywhere, announced that...

Photocure Announces the Publication of Pre-Clinical Study Results Supporting the Anti-tumor Effect of Hexaminolevulinate with Blue Light in Bladder Cancer model

Photocure ASA, the Bladder Cancer Company, announces the publication of new results from its exploratory research program in the journal Biomedicines, entitled "Antitumor Effect...

Celyad Oncology Announces Voluntary Pause of CYAD-101-002 Phase 1b Trial

Celyad Oncology SA, a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer,...
0FansLike
0FollowersFollow
spot_img

Hot Topics